Drug Profile
Research programme: bacterial glycosyltransferase inhibitors - GLYCODesign
Latest Information Update: 22 Aug 2002
Price :
$50
*
At a glance
- Originator GLYCODesign
- Class
- Mechanism of Action Glycosyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 22 Aug 2002 Discontinued - Preclinical for Bacterial infections in Canada (unspecified route)
- 07 Dec 1998 Preclinical development for Bacterial infections in Canada (Unknown route)